Emmi® solutions, from Wolters Kluwer Health, helps healthcare organizations extend the reach of care teams in and beyond the care setting, enabling them to build stronger relationships, enhance the care experience, improve health outcomes and support value-based care initiatives, while increasing revenue and reducing costs. Emmi combines a science-based approach to communications design with healthcare expertise and a patented technology platform that brings dynamic, interactive and personalized communications to life.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

Health Technology

NVIDIA LAUNCHES UK’S MOST POWERFUL SUPERCOMPUTER, FOR RESEARCH IN AI AND HEALTHCARE

NVIDIA | July 07, 2021

news image

NVIDIA today officially launched Cambridge-1, the United Kingdom’s most powerful supercomputer, which will enable top scientists and healthcare experts to use the powerful combination of AI and simulation to accelerate the digital biology revolution and bolster the country’s world-leading life sciences industry. Dedicated to advancing healthcare, Cambridge-1 represents a $100 million investment by NVIDIA. Its first projects with AstraZeneca, GSK, Guy’s and ...

Read More

GE HEALTHCARE ANNOUNCES U.S. FDA 510K CLEARANCE FOR ITS ULTRA EDITION PACKAGE ON VIVID CARDIOVASCULAR ULTRASOUND SYSTEMS

GE Healthcare | October 12, 2020

news image

GE Healthcare today announced U.S. FDA 510k clearance for its Ultra Edition package on Vivid1 cardiovascular ultrasound systems, which includes new features based on artificial intelligence (AI) that enable clinicians to acquire faster, more repeatable exams consistently. Methodical assessments of heart function are key in echocardiography but can be tedious and time-consuming to acquire. High quality data acquisition a...

Read More

Future of Healthcare

PRENOSIS ANNOUNCES INVESTMENT FROM PACE HEALTHCARE CAPITAL, BRINGING TOTAL FUNDING TO OVER $20 MILLION

Prenosis | March 10, 2022

news image

Prenosis, Inc., a precision medicine company,announced a venture investment from PACE Healthcare Capital, an early-stage investment firm committed to improving health outcomes. This investment brings total funding in the company to over$20 million, including partnerships with Foxconn, Roche Diagnostics, the Defense Threat Reduction Agency, and others. Prenosisis leveraging machine learning algorithms trained on deep biological data and broad clinical da...

Read More

KYRUUS, GYANT INTEGRATE TO OFFER AI-ASSISTED PROVIDER SEARCH AND SELF-SCHEDULING

HIT Consultant | March 17, 2020

news image

Kyruus, the provider of provider search and scheduling solutions for health systems, and GYANT, the leading artificial intelligence-enabled virtual assistant for healthcare, today announced a new integration partnership to help health systems enhance consumer access and self-service on their websites. The two companies will join forces to combine the power of Kyruus’ routing and scheduling platform with GYANT’s chat-based virtual assistant to help consumers find and book appropriate ...

Read More
news image

Health Technology

NVIDIA LAUNCHES UK’S MOST POWERFUL SUPERCOMPUTER, FOR RESEARCH IN AI AND HEALTHCARE

NVIDIA | July 07, 2021

NVIDIA today officially launched Cambridge-1, the United Kingdom’s most powerful supercomputer, which will enable top scientists and healthcare experts to use the powerful combination of AI and simulation to accelerate the digital biology revolution and bolster the country’s world-leading life sciences industry. Dedicated to advancing healthcare, Cambridge-1 represents a $100 million investment by NVIDIA. Its first projects with AstraZeneca, GSK, Guy’s and ...

Read More
news image

GE HEALTHCARE ANNOUNCES U.S. FDA 510K CLEARANCE FOR ITS ULTRA EDITION PACKAGE ON VIVID CARDIOVASCULAR ULTRASOUND SYSTEMS

GE Healthcare | October 12, 2020

GE Healthcare today announced U.S. FDA 510k clearance for its Ultra Edition package on Vivid1 cardiovascular ultrasound systems, which includes new features based on artificial intelligence (AI) that enable clinicians to acquire faster, more repeatable exams consistently. Methodical assessments of heart function are key in echocardiography but can be tedious and time-consuming to acquire. High quality data acquisition a...

Read More
news image

Future of Healthcare

PRENOSIS ANNOUNCES INVESTMENT FROM PACE HEALTHCARE CAPITAL, BRINGING TOTAL FUNDING TO OVER $20 MILLION

Prenosis | March 10, 2022

Prenosis, Inc., a precision medicine company,announced a venture investment from PACE Healthcare Capital, an early-stage investment firm committed to improving health outcomes. This investment brings total funding in the company to over$20 million, including partnerships with Foxconn, Roche Diagnostics, the Defense Threat Reduction Agency, and others. Prenosisis leveraging machine learning algorithms trained on deep biological data and broad clinical da...

Read More
news image

KYRUUS, GYANT INTEGRATE TO OFFER AI-ASSISTED PROVIDER SEARCH AND SELF-SCHEDULING

HIT Consultant | March 17, 2020

Kyruus, the provider of provider search and scheduling solutions for health systems, and GYANT, the leading artificial intelligence-enabled virtual assistant for healthcare, today announced a new integration partnership to help health systems enhance consumer access and self-service on their websites. The two companies will join forces to combine the power of Kyruus’ routing and scheduling platform with GYANT’s chat-based virtual assistant to help consumers find and book appropriate ...

Read More